IL-28, IL-29 and their class II cytokine receptor IL-28R.

PubWeight™: 11.22‹?› | Rank: Top 0.1%

🔗 View Article (PMID 12469119)

Published in Nat Immunol on December 02, 2002

Authors

Paul Sheppard1, Wayne Kindsvogel, Wenfeng Xu, Katherine Henderson, Stacy Schlutsmeyer, Theodore E Whitmore, Rolf Kuestner, Ursula Garrigues, Carl Birks, Jenny Roraback, Craig Ostrander, Dennis Dong, Jinu Shin, Scott Presnell, Brian Fox, Betty Haldeman, Emily Cooper, David Taft, Teresa Gilbert, Francis J Grant, Monica Tackett, William Krivan, Gary McKnight, Chris Clegg, Don Foster, Kevin M Klucher

Author Affiliations

1: ZymoGenetics, Inc., 1201 Eastlake Avenue E., Seattle, WA 98102, USA.

Associated clinical trials:

Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases? (ILAND) | NCT02498808

A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection | NCT02765802

Articles citing this

(truncated to the top 100)

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet (2009) 13.03

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19

Lambda interferon inhibits hepatitis B and C virus replication. J Virol (2005) 5.47

Immune signaling by RIG-I-like receptors. Immunity (2011) 5.02

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol (2006) 4.21

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med (2005) 3.59

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol (2004) 3.59

Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol (2007) 3.37

Biology of interleukin-22. Semin Immunopathol (2010) 2.92

The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. Nat Immunol (2013) 2.60

Into the eye of the cytokine storm. Microbiol Mol Biol Rev (2012) 2.58

IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A (2011) 2.47

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28

Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med (2010) 2.26

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J Exp Med (2013) 2.24

Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 2.15

The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med (2006) 1.98

Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol (2005) 1.97

Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol (2009) 1.86

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86

Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol (2008) 1.79

Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol (2005) 1.76

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol (2015) 1.76

Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol (2006) 1.75

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood (2009) 1.75

Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J Virol (2009) 1.74

Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol (2010) 1.73

Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem (2009) 1.73

Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One (2010) 1.73

Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection. Cell Host Microbe (2016) 1.72

Characterization of the murine alpha interferon gene family. J Virol (2004) 1.72

Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog (2010) 1.66

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol (2010) 1.66

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest (2006) 1.66

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production. J Exp Med (2015) 1.65

Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure (2010) 1.63

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies. J Exp Med (2014) 1.61

Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol (2011) 1.61

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology (2011) 1.59

Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection. PLoS Pathog (2014) 1.59

A partial form of recessive STAT1 deficiency in humans. J Clin Invest (2009) 1.59

Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol (2007) 1.58

CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med (2004) 1.56

Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology (2011) 1.53

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections. PLoS Pathog (2016) 1.51

IFN-λs. Curr Opin Immunol (2011) 1.48

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver Int (2010) 1.48

Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology (2014) 1.46

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J (2005) 1.46

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology (2014) 1.46

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther (2008) 1.45

IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol (2017) 1.45

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med (2011) 1.44

Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol (2011) 1.41

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J (2013) 1.40

Signaling by STATs. Arthritis Res Ther (2004) 1.35

25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end. Nat Rev Immunol (2013) 1.35

The role of genomic data in the discovery, annotation and evolutionary interpretation of the interferon-lambda family. PLoS One (2009) 1.34

IFN-λ4: the paradoxical new member of the interferon lambda family. J Interferon Cytokine Res (2014) 1.32

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J Biol Chem (2008) 1.32

Evolutionary genetic dissection of human interferons. J Exp Med (2011) 1.32

Interferon-alfa, interferon-lambda and hepatitis C. Nat Genet (2009) 1.31

Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol (2011) 1.31

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology (2011) 1.30

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol (2006) 1.28

IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol (2004) 1.28

Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer. Cancer Res (2010) 1.27

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS One (2010) 1.26

IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One (2012) 1.25

Interferon lambdas: the next cytokine storm. Gut (2011) 1.25

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe (2016) 1.25

The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci U S A (2009) 1.24

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol (2012) 1.23

Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol (2015) 1.22

Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J Virol (2012) 1.21

Genetics of IL28B and HCV--response to infection and treatment. Nat Rev Gastroenterol Hepatol (2012) 1.20

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy. Proc Natl Acad Sci U S A (2011) 1.19

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Med (2011) 1.19

Trial Watch: Immunostimulatory cytokines. Oncoimmunology (2012) 1.19

Antitumor activity of type I and type III interferons in BNL hepatoma model. Cancer Immunol Immunother (2010) 1.19

IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice. J Gastroenterol (2010) 1.18

Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol (2010) 1.18

Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol (2013) 1.18

The genetic theory of infectious diseases: a brief history and selected illustrations. Annu Rev Genomics Hum Genet (2013) 1.17

Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes. J Leukoc Biol (2012) 1.17

Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol (2006) 1.16

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. Immunity (2015) 1.16

Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLoS One (2012) 1.16

Comparative genomic analysis reveals independent expansion of a lineage-specific gene family in vertebrates: the class II cytokine receptors and their ligands in mammals and fish. BMC Genomics (2003) 1.15

Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog (2013) 1.15

Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics (2010) 1.15

NK cells require IL-28R for optimal in vivo activity. Proc Natl Acad Sci U S A (2015) 1.14

Characterization of the bovine type I IFN locus: rearrangements, expansions, and novel subfamilies. BMC Genomics (2009) 1.13

Articles by these authors

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology (2006) 3.46

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 3.17

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol (2004) 2.65

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol (2014) 2.58

Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol (2007) 2.24

In silico identification of metazoan transcriptional regulatory regions. Naturwissenschaften (2003) 2.18

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood (2003) 2.12

Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity (2013) 2.08

Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother (2009) 2.05

Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol (2004) 2.04

Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol (2005) 1.97

Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem (2002) 1.89

IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol (2002) 1.89

IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood (2008) 1.86

IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) (2009) 1.76

IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol (2003) 1.70

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med (2011) 1.44

Transobturator male sling: is there a learning curve? Can J Urol (2013) 1.41

Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur J Immunol (2011) 1.36

Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiol Lett (2004) 1.32

Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Ann Surg Oncol (2011) 1.27

Cytokine requirements for the growth and development of mouse NK cells in vitro. J Leukoc Biol (2003) 1.27

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol (2012) 1.23

Adverse events of acupuncture: a systematic review of case reports. Evid Based Complement Alternat Med (2013) 1.23

Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007. J Clin Microbiol (2007) 1.18

Body dissatisfaction, dietary restraint, depression, and weight status in adolescents. J Sch Health (2010) 1.09

The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology (2002) 1.08

Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control (2012) 1.05

Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort. Breast Cancer Res (2010) 1.02

Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer. Ann Surg Oncol (2011) 1.02

Interferon lambda as a potential new therapeutic for hepatitis C. Ann N Y Acad Sci (2009) 1.00

Engineering of stable bispecific antibodies targeting IL-17A and IL-23. Protein Eng Des Sel (2009) 1.00

Cytokine-receptor pairing: accelerating discovery of cytokine function. Nat Rev Drug Discov (2004) 0.97

A qualitative study of choosing home health care after hospitalization: the unintended consequences of 'patient choice' requirements. J Gen Intern Med (2015) 0.97

The relation between weight-based teasing and psychological adjustment in adolescents. Paediatr Child Health (2010) 0.95

Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes. Br J Haematol (2013) 0.94

Identification of antimicrobial targets using a comprehensive genomic approach. Pharmacogenomics (2004) 0.93

Human IL-21 and IL-4 bind to partially overlapping epitopes of common gamma-chain. Biochem Biophys Res Commun (2003) 0.93

Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animals. ACS Chem Biol (2013) 0.93

Exploring avoidant/restrictive food intake disorder in eating disordered patients: a descriptive study. Int J Eat Disord (2013) 0.91

Pilot estuarine mesocosm study on the environmental fate of Silver nanomaterials leached from consumer products. Sci Total Environ (2012) 0.90

The diffusion of youth-led participatory research in urban schools: the role of the prevention support system in implementation and sustainability. Am J Community Psychol (2008) 0.89

Family meals and body mass index among adolescents: effects of gender. Appl Physiol Nutr Metab (2011) 0.89

Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma. Bioorg Med Chem Lett (2009) 0.89

A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo. MAbs (2010) 0.88

Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial. BMC Pediatr (2008) 0.88

Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors. Bioorg Med Chem Lett (2010) 0.87

Kinetic and structural investigations into the allosteric and pH effect on the substrate specificity of human epithelial 15-lipoxygenase-2. Biochemistry (2013) 0.86

A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma. J Transl Med (2014) 0.86

Reproducibility of oxygen saturation monitoring during six-minute walk test and exercise stress test in patients with pulmonary arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Pediatr Cardiol (2011) 0.84

Internalization of the thin and muscular body ideal and disordered eating in adolescence: the mediation effects of body esteem. Body Image (2011) 0.83

Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia. MAbs (2010) 0.83

Individual care plans can reduce hospital admission rate for patients who frequently attend the emergency department. Emerg Med J (2010) 0.83

Creating and evaluating a data-driven curriculum for central venous catheter placement. J Grad Med Educ (2010) 0.83

Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease. Neuromuscul Disord (2002) 0.83

Physical activity and psychological adjustment in adolescents. J Phys Act Health (2011) 0.82

Visualization of Src and FAK activity during the differentiation process from HMSCs to osteoblasts. PLoS One (2012) 0.82

An audit of first seizures presenting to an Accident and Emergency department. Seizure (2005) 0.82

A long-term monitoring study of chlorophyll, microbial contaminants, and pesticides in a coastal residential stormwater pond and its adjacent tidal creek. Environ Monit Assess (2011) 0.82

Utilization of mastectomy and reconstruction in the outpatient setting. Ann Surg Oncol (2012) 0.81

Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models. PLoS One (2013) 0.81

Gene finding for the helical cytokines. Bioinformatics (2005) 0.81

Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeys. J Interferon Cytokine Res (2012) 0.81

Invasive Nontuberculous Mycobacterial Infections among Cardiothoracic Surgical Patients Exposed to Heater-Cooler Devices(1). Emerg Infect Dis (2017) 0.81

Effects of post-training heroin and d-amphetamine on consolidation of win-stay learning and fear conditioning. J Psychopharmacol (2013) 0.80

Transitory FGF treatment results in the long-lasting suppression of the proliferative response to repeated FGF stimulation. J Cell Biochem (2014) 0.79

Comparative distribution and validity of DSM-IV and DSM-5 diagnoses of eating disorders in adolescents from the community. Eur Eat Disord Rev (2014) 0.78

The effect of differentiation induction on FAK and Src activity in live HMSCs visualized by FRET. PLoS One (2013) 0.78

Generation and characterization of human anti-human IL-21 neutralizing monoclonal antibodies. MAbs (2012) 0.77

Pain impacts on quality of life and interferes with treatment in adults with cystic fibrosis. Physiother Res Int (2011) 0.77

Finding evidence to support practice in allied health: peers, experience, and the internet. J Allied Health (2012) 0.77

Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia. Am J Health Syst Pharm (2005) 0.76

Generation of a high-affinity Fcgamma receptor by Ig-domain swapping between human CD64A and CD16A. Protein Eng Des Sel (2010) 0.76

Improving older trauma patients' outcomes through targeted occupational therapy and functional conditioning. Am J Occup Ther (2012) 0.76

Risk of colorectal cancer associated with active smoking among female teachers. Cancer Causes Control (2013) 0.76

Foundation year for newly qualified doctors: GMC assessment of junior doctors' competency is inadequate or inconsistent. BMJ (2005) 0.75

Recreational amitriptyline toxicity mimicking basilar artery stroke. Eur J Emerg Med (2013) 0.75

Interlaboratory comparison of extraction efficiency of pesticides from surface and laboratory water using solid-phase extraction disks. J Agric Food Chem (2003) 0.75

Statistics of retinal image blur during natural viewing. J Vis (2015) 0.75

What are the natural scene statistics of cortical input? J Vis (2015) 0.75

Navigating the territory of job design. Appl Ergon (2002) 0.75

Psychosocial analysis of HIV/AIDS-related stigma in South Africa. Int Q Community Health Educ (2009) 0.75